Literature DB >> 23448386

A statewide survey of practitioners to assess knowledge and clinical practices regarding hereditary breast and ovarian cancer.

Tuya Pal1, Deborah Cragun, Courtney Lewis, Andrea Doty, Maria Rodriguez, Cristi Radford, Zachary Thompson, Jongphil Kim, Susan T Vadaparampil.   

Abstract

PURPOSE: This study describes practitioner knowledge and practices related to BRCA testing and management and explores how training may contribute to practice patterns.
METHODS: A survey was mailed to all BRCA testing providers in Florida listed in a publicly available directory. Descriptive statistics characterized participants and their responses.
RESULTS: Of the 87 respondents, most were community-based physicians or nurse practitioners. Regarding BRCA mutations, the majority (96%) recognized paternal inheritance and 61% accurately estimated mutation prevalence. For a 35-year-old unaffected BRCA mutation carrier, the majority followed national management guidelines. However, 65% also recommended breast ultrasonography. Fewer than 40% recognized the need for comprehensive rearrangement testing when BRACAnalysis(®) was negative in a woman at 30% risk. Finally, fewer than 15% recognized appropriate testing for a BRCA variant of uncertain significance. Responses appeared to be positively impacted by presence and type of cancer genetics training.
CONCLUSIONS: In our sample of providers who order BRCA testing, knowledge gaps in BRCA prevalence estimates and appropriate screening, testing, and results interpretation were identified. Our data suggest the need to increase regulation and oversight of genetic testing services at a policy level, and are consistent with case reports that reveal liability risks when genetic testing is conducted without adequate knowledge and training.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23448386      PMCID: PMC3634150          DOI: 10.1089/gtmb.2012.0381

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  35 in total

Review 1.  Use and interpretation of genetic tests in cardiovascular genetics.

Authors:  Colleen Caleshu; Sharlene Day; Heidi L Rehm; Samantha Baxter
Journal:  Heart       Date:  2010-10       Impact factor: 5.994

2.  Physician exposure to and attitudes toward advertisements for genetic tests for inherited cancer susceptibility.

Authors:  Susan Thomas Vadaparampil; Louise Wideroff; Lorayn Olson; K Viswanath; Andrew N Freedman
Journal:  Am J Med Genet A       Date:  2005-05-15       Impact factor: 2.802

Review 3.  Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2005-09-06       Impact factor: 25.391

4.  A portable, unobtrusive device for videorecording clinical interactions.

Authors:  Terrance L Albrecht; John C Ruckdeschel; Fountain L Ray; Ben J Pethe; Dawn L Riddle; Joan Strohm; Louis A Penner; Michael D Coovert; Gwendolyn Quinn; Christina G Blanchard
Journal:  Behav Res Methods       Date:  2005-02

5.  Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors.

Authors:  Bronson D Riley; Julie O Culver; Cécile Skrzynia; Leigha A Senter; June A Peters; Josephine W Costalas; Faith Callif-Daley; Sherry C Grumet; Katherine S Hunt; Rebecca S Nagy; Wendy C McKinnon; Nancie M Petrucelli; Robin L Bennett; Angela M Trepanier
Journal:  J Genet Couns       Date:  2011-12-02       Impact factor: 2.537

6.  Which individuals undergoing BRACAnalysis need BART testing?

Authors:  Kristen M Shannon; Linda H Rodgers; Gayun Chan-Smutko; Devanshi Patel; Michele Gabree; Paula D Ryan
Journal:  Cancer Genet       Date:  2011-08

7.  Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians.

Authors:  L Wideroff; S T Vadaparampil; M H Greene; S Taplin; L Olson; A N Freedman
Journal:  J Med Genet       Date:  2005-03-22       Impact factor: 6.318

8.  Reading between the lines: direct-to-consumer advertising of genetic testing in the USA.

Authors:  S C Hull; K Prasad
Journal:  Reprod Health Matters       Date:  2001-11

9.  Assessment of false-negative cases of breast MR imaging in women with a familial or genetic predisposition.

Authors:  Inge-Marie A Obdeijn; Claudette E Loo; Adriana J Rijnsburger; Martin N J M Wasser; Elisabeth Bergers; Theo Kok; Jan G M Klijn; Carla Boetes
Journal:  Breast Cancer Res Treat       Date:  2010-01       Impact factor: 4.872

10.  Genetic/familial high-risk assessment: breast and ovarian, version 1.2014.

Authors:  Mary B Daly; Robert Pilarski; Jennifer E Axilbund; Saundra S Buys; Beth Crawford; Susan Friedman; Judy E Garber; Carolyn Horton; Virginia Kaklamani; Catherine Klein; Wendy Kohlmann; Allison Kurian; Jennifer Litton; Lisa Madlensky; P Kelly Marcom; Sofia D Merajver; Kenneth Offit; Tuya Pal; Boris Pasche; Gwen Reiser; Kristen Mahoney Shannon; Elizabeth Swisher; Nicoleta C Voian; Jeffrey N Weitzel; Alison Whelan; Georgia L Wiesner; Mary A Dwyer; Rashmi Kumar
Journal:  J Natl Compr Canc Netw       Date:  2014-09       Impact factor: 11.908

View more
  32 in total

1.  Factors which impact the delivery of genetic risk assessment services focused on inherited cancer genomics: expanding the role and reach of certified genetics professionals.

Authors:  Cristi Radford; Anya Prince; Karen Lewis; Tuya Pal
Journal:  J Genet Couns       Date:  2013-12-04       Impact factor: 2.537

2.  Genetic counselors' practices and confidence regarding variant of uncertain significance results and reclassification from BRCA testing.

Authors:  C L Scherr; N M Lindor; T L Malo; F J Couch; S T Vadaparampil
Journal:  Clin Genet       Date:  2015-02-26       Impact factor: 4.438

Review 3.  BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance.

Authors:  D M Eccles; G Mitchell; A N A Monteiro; R Schmutzler; F J Couch; A B Spurdle; E B Gómez-García
Journal:  Ann Oncol       Date:  2015-07-07       Impact factor: 32.976

4.  An Applied Framework in Support of Shared Decision Making about BRCA Genetic Testing.

Authors:  Thomas B Silverman; Gilad J Kuperman; Alejandro Vanegas; Margaret Sin; Jill Dimond; Katherine D Crew; Rita Kukafka
Journal:  AMIA Annu Symp Proc       Date:  2018-12-05

5.  A theory-informed systematic review of clinicians' genetic testing practices.

Authors:  Jean L Paul; Hanna Leslie; Alison H Trainer; Clara Gaff
Journal:  Eur J Hum Genet       Date:  2018-06-11       Impact factor: 4.246

6.  Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial.

Authors:  Anita Y Kinney; Rachel Howell; Rachel Ruckman; Jean A McDougall; Tawny W Boyce; Belinda Vicuña; Ji-Hyun Lee; Dolores D Guest; Randi Rycroft; Patricia A Valverde; Kristina M Gallegos; Angela Meisner; Charles L Wiggins; Antoinette Stroup; Lisa E Paddock; Scott T Walters
Journal:  Contemp Clin Trials       Date:  2018-09-18       Impact factor: 2.226

7.  BRCA sequencing and large rearrangement testing in young Black women with breast cancer.

Authors:  Tuya Pal; Devon Bonner; Deborah Cragun; Sharland Johnson; Mohammad Akbari; Lily Servais; Steven Narod; Susan Vadaparampil
Journal:  J Community Genet       Date:  2013-08-29

8.  Physician Risk Assessment Knowledge Regarding BRCA Genetics Testing.

Authors:  Jason Cohn; William Blazey; David Tegay; Brian Harper; Sharon Koehler; Brookshield Laurent; Vivian Chan; Min-Kyung Jung; Bhuma Krishnamachari
Journal:  J Cancer Educ       Date:  2015-09       Impact factor: 2.037

9.  Evolution of Hereditary Breast Cancer Genetic Services: Are Changes Reflected in the Knowledge and Clinical Practices of Florida Providers?

Authors:  Deborah Cragun; Courtney Scherr; Lucia Camperlengo; Susan T Vadaparampil; Tuya Pal
Journal:  Genet Test Mol Biomarkers       Date:  2016-08-15

10.  The effect of referral for genetic counseling on genetic testing and surgical prevention in women at high risk for ovarian cancer: Results from a randomized controlled trial.

Authors:  Charles W Drescher; J David Beatty; Robert Resta; M Robyn Andersen; Kate Watabayashi; Jason Thorpe; Sarah Hawley; Hannah Purkey; Jessica Chubak; Nancy Hanson; Diana S M Buist; Nicole Urban
Journal:  Cancer       Date:  2016-07-22       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.